Literature DB >> 17932254

The genomic landscapes of human breast and colorectal cancers.

Laura D Wood1, D Williams Parsons, Siân Jones, Jimmy Lin, Tobias Sjöblom, Rebecca J Leary, Dong Shen, Simina M Boca, Thomas Barber, Janine Ptak, Natalie Silliman, Steve Szabo, Zoltan Dezso, Vadim Ustyanksky, Tatiana Nikolskaya, Yuri Nikolsky, Rachel Karchin, Paul A Wilson, Joshua S Kaminker, Zemin Zhang, Randal Croshaw, Joseph Willis, Dawn Dawson, Michail Shipitsin, James K V Willson, Saraswati Sukumar, Kornelia Polyak, Ben Ho Park, Charit L Pethiyagoda, P V Krishna Pant, Dennis G Ballinger, Andrew B Sparks, James Hartigan, Douglas R Smith, Erick Suh, Nickolas Papadopoulos, Phillip Buckhaults, Sanford D Markowitz, Giovanni Parmigiani, Kenneth W Kinzler, Victor E Velculescu, Bert Vogelstein.   

Abstract

Human cancer is caused by the accumulation of mutations in oncogenes and tumor suppressor genes. To catalog the genetic changes that occur during tumorigenesis, we isolated DNA from 11 breast and 11 colorectal tumors and determined the sequences of the genes in the Reference Sequence database in these samples. Based on analysis of exons representing 20,857 transcripts from 18,191 genes, we conclude that the genomic landscapes of breast and colorectal cancers are composed of a handful of commonly mutated gene "mountains" and a much larger number of gene "hills" that are mutated at low frequency. We describe statistical and bioinformatic tools that may help identify mutations with a role in tumorigenesis. These results have implications for understanding the nature and heterogeneity of human cancers and for using personal genomics for tumor diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932254     DOI: 10.1126/science.1145720

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  1404 in total

1.  The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.

Authors:  Emilia Solomon; Hui Li; Sara Duhachek Muggy; Emilia Syta; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 2.  Practicing pathology in the era of big data and personalized medicine.

Authors:  Jiang Gu; Clive R Taylor
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-01

3.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

Authors:  Sergei I Grivennikov; Kepeng Wang; Daniel Mucida; C Andrew Stewart; Bernd Schnabl; Dominik Jauch; Koji Taniguchi; Guann-Yi Yu; Christoph H Osterreicher; Kenneth E Hung; Christian Datz; Ying Feng; Eric R Fearon; Mohamed Oukka; Lino Tessarollo; Vincenzo Coppola; Felix Yarovinsky; Hilde Cheroutre; Lars Eckmann; Giorgio Trinchieri; Michael Karin
Journal:  Nature       Date:  2012-11-08       Impact factor: 49.962

4.  RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancer.

Authors:  Olga V Leontieva; Yuri Ionov
Journal:  Cell Cycle       Date:  2009-02-22       Impact factor: 4.534

5.  APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway.

Authors:  Guihua Wang; Feng Wang; Weifeng Ding; Jingchun Wang; Rongrong Jing; Haiquan Li; Xudong Wang; Yueguo Wang; Shaoqing Ju; Huimin Wang
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

Review 6.  Tumor heterogeneity in the clinic: is it a real problem?

Authors:  Filip Janku
Journal:  Ther Adv Med Oncol       Date:  2014-03       Impact factor: 8.168

Review 7.  Intestinal stem cells and the colorectal cancer microenvironment.

Authors:  Bryan A Ong; Kenneth J Vega; Courtney W Houchen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 8.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

9.  From the Cover: PhIP/DSS-Induced Colon Carcinogenesis in CYP1A-Humanized Mice and the Possible Role of Lgr5+ Stem Cells.

Authors:  Jayson X Chen; Hong Wang; Anna Liu; Lanjing Zhang; Kenneth Reuhl; Chung S Yang
Journal:  Toxicol Sci       Date:  2016-09-23       Impact factor: 4.849

10.  Getting personal with neoantigen-based therapeutic cancer vaccines.

Authors:  Nir Hacohen; Edward F Fritsch; Todd A Carter; Eric S Lander; Catherine J Wu
Journal:  Cancer Immunol Res       Date:  2013-04-07       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.